Pulmonary toxicity in patients receiving docetaxel chemotherapy.


Pulmonary toxicity can rarely be seen with cytotoxic agents. We aimed at investigating the pulmonary toxicity of docetaxel in patients other than lung carcinoma. Forty patients were investigated prospectively. Spirometry, DLCO and high-resolution computed tomography (HRCT) scans were applied to all patients before and 14-21 days after completion of… (More)
DOI: 10.1007/s12032-009-9391-9


7 Figures and Tables

Slides referencing similar topics